A reversible target capture viral RNA extraction procedure was combined with a reverse-transcriptase nested polymerase chain reaction (PCR) to develop a capture PCR assay providing a rapid and safe prediction method for circulating bluetongue virus in infected ruminants. This new assay was compared with virus isolation and a recently developed antigen-capture enzyme-linked immunosorbent assay (ELISA) for the detection of bluetongue virus. Eight Warhill crossbred sheep were inoculated subcutaneously with bluetongue virus serotype 10, and blood samples were taken sequentially over a period of 28 days. The capture PCR detected the peak of viremia, as determined by virus isolation and antigen-capture ELISA, from day 5 to day 14 after challenge. The results indicate that the rapid-capture bluetongue virus PCR provides a rapid indicator of samples in which virus can be isolated. In addition, this capture bluetongue virus PCR procedure does not require a lengthy phenol extraction or the use of the highly toxic methyl mercury hydroxide denaturant. type 2 (BTV-2, Ona B strain), BTV serotype 10 (BTV-10,
Bluetongue is an infectious, noncontagious, arthropod-borne viral infection of domestic and wild ruminants. 16 The infection is usually most severe in domestic sheep although white-tailed deer (Odocoileus Virginianus), pronghom antelope ( ntilocapra americana), and desert bighorn sheep (Ovis canadensis) have also been reported to be susceptible to the disease. 22 Bluetongue viruses (BTV) belong to the genus Orbivirus in the family Reoviridae. 11 There are 25 serotypes of BTV currently recognized worldwide. 8 The diversity of viral serotypes and the wide host range of BTV complicates the development of diagnostic procedures. Two general types of tests primarily have been used in diagnostic veterinary medicine. Serologic assays, such as the complement fixation test, the agar gel immunodiffusion test, and the more current competitive enzyme-linked immunosorbent assays (ELISAs), are useful in detecting animals that have had prior exposure to BTV; 1,24 however, they do not answer questions regarding the current state of viremia in an animal. 9 Virus isolation techniques were developed in the late 1960s using embryonated chicken eggs (ECE); 10 and more recently, permissive cell cultures such as bovine An antigen-capture ELISA was developed to detect BTV in the insect vector Culicoides variipennis. 20 This procedure has been adapted to detect BTV in the blood of infected animals and is comparable in sensitivity to assays in cell culture for detection of virus; in addition, it identifies BTV without additional serologic assays. 19 However, this technique still requires amplification of the virus in cell culture before positive identification. Researchers have sought more direct detection methods for virus in insects and infected animals. 25 Assays based on amplification of viral nucleic acid by the polymerase chain reaction (PCR) have been extremely valuable for the direct detection of BTV in biological samples. 2, 13, 14, 18, 29, 33 Virus isolation, however, is still needed for positive identification or confirmation of BTV infection.
The purpose of this study was to develop a reversible target capture viral RNA extraction procedure combined with a reverse-transcriptase nested PCR (capture PCR) for detection of BTV RNA in blood samples from infected animals. This procedure is better than previous PCR tests because it avoids the use of laborintensive RNA extraction procedures and the use of endothelial cells have been employed. 31 Modern ditoxic chemicals. Because virus isolation is used as conagnostic tools using immunohistochemical techniques, firmation of PCR detection procedures and is desirable including immunofluorescent, 23, 28 immunoperoxiin field investigations, the capture PCR was designed dase, 3,6,30 and immunogold staining, 12 have also been to predict peak viremia. This assay is described and applied.
compared with conventional BTV isolation and antigen-capture ELISA procedures.
BT-8 strain), BTV serotype 11 (BTV-11, Station strain), BTV serotype 13 (BTV-13,67-41 B strain), BTV serotype 17 (BTV-17, 63-66B strain), epizootic hemorrhagic disease virus (EHDV) serotype 1 (EHDV-1, New Jersey strain), and EHDV serotype 2 (EHDV-2, Alberta strain). Animals and sampling procedures. Eight yearling Warhill crossbred (Targhee and Rambouillet) female sheep were obtained locally in Wyoming. These animals were clinically normal and tested negative for BTV and BTV-specific antibodies by virus isolation, PCR, and ELISA methods as described previously. 17 Whole blood samples were obtained in heparin and in sodium citrate-treated vacutainer a tubes at 0, 5, 7, 9, 11, 14, 21 , and 28 days after challenge (DAC) for virus isolation and PCR and were stored at 4 C. Whole blood samples were taken at the same intervals prior to the challenge day from 2 sheep and used as control samples. In addition, blood samples were collected at 0, 7, 14, 21, and 28 DAC for retrieval of serum.
Experimental design. During preexperiment studies, 2 sheep (nos. 7, 8) were inoculated subcutaneously with 1 ml of blood from a calf infected with BTV-10 to test the virulence of the virus prior to exposing the other experimental sheep to a challenge dose. These sheep were observed for 42 days. Both sheep showed viremia as detected by virus isolation and by PCR. 17 The 6 remaining sheep (nos. 1-6) were kept in a C. variipennis-free facility. During this pretreatment, blood samples were taken, using the same sampling time scheme, from 2 of these 6 sheep (nos. 1, 3) and used as uninfected controls. After the initial 42 days, all 8 sheep were inoculated subcutaneously with BTV-10 (1 ml, 2 x 10 5 CCID 50 ) and housed in insect-free facilities. The sheep were monitored daily for clinical signs.
Virus isolation and antigen-capture ELISA. Virus isolation by ECE inoculation and subsequent cell-culture confirmation were performed as described previously. 31 Cell-culture virus isolation and antigen-capture ELISA were performed as previously described, 19 except that blood was diluted with sterile water instead of being sonicated to release virus particles. Supernatant fluids were collected 6 and 12 days after inoculation (DAI) from the cell cultures and assayed for virus in the antigen-capture ELISA. 19 A polyclonal rabbit anti-BTV serum was used as the capture antibody and a monoclonal antibody (1AA4.E4) 20 was used as the detector antibody.
Competitive ELISA (cELISA). The cELISA was performed to monitor antibody response in experimentally infected animals. Serum samples collected at 0, 7, 11, 14, 21, and 28 DAC were tested using a commercially available kit. b PCR. The target RNA was BTV RNA genome segment 6, which codes for nonstructural protein 1 (NS1). The PCR procedure was similar to that described previously for EHDV. 32 The nested PCR products were analyzed by a commercial rapid calorimetric detection procedure designated DIANA (detection of immobilized amplified nucleic acids) c and by agarose gel electrophoresis followed by staining with ethidium bromide. The various conditions for PCR, such as the amount of extraction biotinylated oligonucleotides, streptavidin-coated magnetic beads, PCR temperature cycles, concentration of enzyme, and sensitivity and specificity of the specific primers, were optimized using purified BTV dou-ble-stranded RNA (dsRNA), BTV-negative blood, and cell cultures infected with the different serotypes.
A set of 5' biotinylated oligonucleotides, designated BT NS1-9RB and BT NS1-402LB, were used for capturing BTV serogroup-specific gene segment NS1 from samples in the extraction buffer. Primers for the reverse trascriptase and first-round PCR (oBTV, BT NS1-9R, BT10 NS1-402L) were unlabeled. Nested primers (iBTV) were designed for PCR amplification of an internal DNA fragment from the firstround PCR product. These primers were labeled at their 5' ends: BTNS1-108RB was biotinylated, and BT10 NS1-325L lac and BT2 NS1-325L lac were tailed with Lac I operon (21nucleotide DNA sequence having binding affinity for Laclß-galactosidase fusion protein c ). This labeling allows for the magnetic capture of the PCR product necessary for the DI-ANA calorimetric detection system. Primers were synthesized by a DNA/RNA synthesizer. d The primers' nucleotide sequences were based on that of BTV-2 or BTV-10 NS1 genes (Table 1) .
Extraction was performed as described previously 14 except that the reversible target capture was substituted for phenol extraction. One milliliter of sodium citrate-treated blood was lysed in 2 ml of autoclaved sterile ice-cold 10 mM Tris-HCl e (pH 8.0). The cellular membranes were collected by centrifugation. The combined erythrocytic/leukocytic membranous pellet was mixed in 100 µl of sterile water. This suspension was mixed with 300 µl of extraction buffer (4 M guanidine thiocyanate, f 0.1 M Tris-HC1 [pH 8.0], 1% dithiothreitol e [DTT], 0.5% laural sarcocinate [Sarcosyl g ]). 7 The mixture was heated at 95 C for 10 min to denature BTV dsRNA and then was plunged into ice. Fifty picomols of each biotinylated capture-extraction primer and 50 µl of washed M280 strepavidin-coated magnetic Dynabeads c were added to the extraction mixture. After mixing gently, the mixture was incubated with gentle mixing at 45 C for 30 min so that labeled extraction primers could anneal with the viral RNA. The reaction tubes were then briefly transferred to ice, and the magnetic Dynabeads were collected, washed twice with sterile ice cold washing buffer (100 mM Tris-HCl [pH 8.0], 400 mM lithium chloride, e 20 mM ethylenediaminetetraacetic acid), and once with 10 mM Tris-HCl (pH 8.0) using the magnetic particles concentrator. c The collected Dynabead-RNA complex was resuspended in 5 µl of 10 mM Tris-HCl (pH 8.0) and either stored at -80 C or used for the reversetranscriptase reaction.
For reverse transcription, the RNA was denatured using 50% formamide f and heat (95 C for 10 min). Reverse transcriptase mix (50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 mM MgC1 2 , 0.02 M DTT, e 0.5 mM dNTP, h iBTV primer mix, RNasin i [40 units], 1.0 µl M-MLV reverse transcriptase j [200 units]) were added, and the reaction mixture was incubated at 37 C for 1 hr and then at 95 C for 5 min.
In the first PCR, 5 µl of the reverse transcriptase reaction product was added to 20 µl of the first PCR mix (10 mM Tris-HCl [pH 8.3], 50 mM KCl, 1.5 mM MgCl 2 , 0.001% [w/ v] gelatin, 0.2 mM dNTP, oBTV primer mix, and Ampli Taq DNA polymerase h [2.5 units]) and overlaid with light mineral oil. e The first PCR reaction conditions were 95 C for 0.5 min, 52 C for 1 min, and 72 C for 2 min, with 5 min in the final cycle, for a total of 40 cycles. In the second PCR, S-labeled nested primers that anneal to DNA sequences within the DNA fragment amplified in the first PCR were employed. Five microliters of the first PCR product was transferred to 45 µl of the second PCR mix (same final concentrations as in the first PCR, except that the iBTV primer mix was substituted for the oBTV primer mix). The second PCR was carried out for 25 cycles of 95 C for 0.5 min, 52 C for 1 min, and 72 C for 2 minutes, with 5 minutes in the final cycle. The PCR products were analyzed according to the protocol for DIANA. c An amplified DNA product of the expected size (239 bp) was detected by agarose gel electrophoresis (2% gel) and staining with ethidium bromide.
Results
Animal response. Sheep that had been previously infected with BTV-10 showed no clinical signs after reinfection with BTV-10. Fully susceptible sheep (not previously exposed to BTV-10) showed variable clinical responses after inoculation with BTV-10. Clinical signs included depression, anorexia, and elevated body temperature ranging from 40.06 to 41.00 C (104.1-107.6 F).
Virus isolation. The viremic pattern as determined by ECE inoculation was typical of experimental sheep infection studies at our facility. In the cell-culture virus isolation, the initial dilution of blood in sterile water resulted in the lysing of blood cells to release virus and also reduced the toxicity to Vero cells due to hemo-1 globin and other cytosolic components. The cytopathic effect (CPE) in Vero cells began to be evident by 6 DAI (< 50%). Supernatant fluids collected on 6 DAI were initially used for the antigen-capture ELISA. To increase the ability of the test to detect viral antigen, the assay was extended 6 days. By keeping the plates up to 12 DAI, maximum CPE was observed. Virus was isolated from only 4 out of 6 sheep without previous exposure, notably from 3 sheep at 9 DAI and from 1 sheep at 11 DAI. The control blood samples were all negative by virus isolation.
Bluetongue antigen-capture ELISA. Performing the antigen-capture ELISA on the cell culture supernatants at 12 DAI rather than 6 DAI increased the efficiency of the test by 50%. All 8 sheep were BTV negative by antigen-capture ELISA prior to viral challenge. Two sheep that had no previous exposure to BTV remained BTV negative by virus isolation and antigen-capture ELISA throughout the experiment. Four sheep were BTV positive by virus isolation on 5, 7, 9, and 11 DAC and by antigen-capture ELISA. No virus could be isolated or detected by antigen-capture ELISA in the 2 previously exposed sheep ( Table 2 ). The control blood samples were all negative by antigen-capture ELISA.
Extraction of viral RNA. The optimal amount of biotinylated extraction primers for use in blood sample extraction was examined. With 10 pmol each of BT NS1-9RB and BT NS1-402LB extraction primers, results were negative prior to challenge and positive for 3 sheep at 5 DAC. With 50 pmol each of the extraction primers, PCR products were consistently detected in 4 sheep at 7 and 9 DAC and in 1 sheep at 7 DAC. Thus, for early detection, 10 pmol of extraction primers gave more consistent results, but to detect the peak of viremia 50 pmol of extraction primer was preferable Bluetongue virus PCR. The amplification of the cDNA product was carried out in 2 PCR steps. With Purified RNA from all of the North American BTV serotypes (BTV-2, BTV-10, BTV-11, BTV-13, BTV-17) were positive with the DIANA and by agarose gel electrophoresis (Fig. 1) . Slightly weaker signals were noted for BTV-2; therefore, the BTV-2 inner primer was added to the iBTV primer mix. The samples of EHDV-1 and EHDV-2 and the water control were negative (Fig. 1) . The results of the DIANA color detection system were similar to the gel electrophoresis results. BTV-11 virus stock was diluted to 1,000, 100, 10, and 1 CCID 50 /0.5 ml of blood to approximate the sensi-239 bp tivity of the capture PCR test. Strong signals were observed in the agarose gel for 100 and 10 CCID 50 , and a faint band was obtained with 1 CCID 50 (data not shown). Color detection by DIANA resulted in an average optical density of 0.56 for 10 CCID 50 /0.5 ml blood.
Two sheep without previous exposure and the 2 previously exposed sheep (nos. 1, 2) were negative by capture PCR. Positive capture PCR results (Fig. 2) were obtained postinfection for 4 of 6 sheep (nos. 3-6) that had no previous BTV exposure. The results of both the agarose gel electrophoresis and the color detection system were in agreement, except in 2 sheep (nos. 3, 8), which had positive samples by the DIANA method but not by gel electrophoresis. These DIANApositive samples were < 100-bp DNA products by agarose gel electrophoresis and only observed after the sheep had cleared the BTV infection, as measured by virus isolation and antigen-capture ELISA. The problem of nonspecific amplification, as detected by gel electrophoresis in these samples, was solved by reducing the annealing time of the primers to 30 seconds in the first PCR; however, the color detection from some of these samples was still positive. Reduction of the annealing time, when repeated with positive samples, did not affect the sensitivity of the capture PCR. The control blood samples were negative by both detection methods.
c-ELISA. The previously exposed sheep were se- ples from from BTV 11, 14, 21, L:100-bp uct.
Agarose gel analysis of PCR products from blood sama BTV-infected sheep (no. 4). Lanes 1-8: PCR products RNA extracted from blood samples collected 0, 5, 7, 9, and 28 days after challenge; lane 9: water control; lane DNA ladder. Arrow identifies region of the 239-bp prodropositive prior to challenge and maintained high antibody levels throughout the experiment. In the other 6 sheep (no previous exposure), seroconversions were observed at 7 DAC for 3 sheep, at 14 DAC for 2 sheep, and at 21 DAC for 1 sheep. The 2 sheep (nos. 1, 2) that were virus isolation, antigen-capture ELISA, and capture PCR negative expressed low antibody levels following experimental inoculation of BTV-10 (Table  2) . These 2 sheep did not have neutralizing antibodies to BTV-10 at 0 DAI but did display neutralizing antobodies by 28 DAI.
Discussion
Monitoring and control of BTV infection in both cattle and sheep remains a top priority among BTVendemic countries interested in exporting livestock free of this infection or in restricting the introduction of new serotypes into already existing endemic populations. 21, 27 Rapid detection assays have been developed recently to detect the presence of BTV antigens, nucleic acid, and antibodies. PCR is a powerful tool in the field of diagnostic medicine and has been used successfully in identifying several infectious diseases of veterinary importance. 4,33 By using the PCR technique, researchers may circumvent problems such as serologic crossreactions among related orbiviruses. 26 To develop a simple and rapid PCR protocol to detect BTV RNA directly from blood, a modification of the reversible target capture hybridization procedure described for dengue-2 virus was chosen.5 RNA extraction was achieved by utilizing biotinylated extraction primers and Dynabeads (M-280 streptavidin) and extraction buffer containing guanidine thiocyanate. Use of the magnetic-bead capture protocol eliminated the lengthy phenol-chloroform/ethanol precipitation RNA extraction procedures. The RNA capture was completed in < 2 hours for 8 specimens, and the entire capture PCR procedure can be completed in 1 day. Some other reverse transcriptase PCR procedures for detecting BTV RNA use the highly toxic denaturant methyl mercury hydroxide. 2, 14 In this study, formamide was used instead of methyl mercury hydroxide, as described for another PCR test for detecting BTV RNA segment 3. 18 The result is a BTV PCR test that is safe and easy to perform.
Color-positive but gel-electrophoresis-negative results were obtained with some samples from sheep that had cleared a virus infection, as shown by virus isolation. These positive results were determined to be the result of a small nonspecific PCR product. This product was noted with sheep nos. 8, 3 but only after BTV was cleared, as determined by conventional diagnostic tests. Therefore, DIANA color detection may be useful for screening large numbers of samples; however, positive samples should be confirmed by gel electrophoresis. The detection of viral RNA in virus-isolation-negative samples has been reported by other investigators using a calorimetric nested PCR. 15 Further examination indicated that these virus-isolationnegative/PCR-positive blood samples did not contain infectious virus. 17 These virus-isolation-negative/PCRpositive samples may contain residual viral RNA or RNA from noninfectious virus particles. The gel electrophoresis detection method is recommended because no PCR gel-positive samples were detected other than around the peak of viremia, as determined by antigencapture ELISA or ECE.
The lack of viremia found with sheep nos. 1 and 2 is suprising considering they received the same BTV inoculum as did the other sheep. This lack did not appear to result from prior immunity to BTV, because neither c-ELISA or neutralizing antibody could be detected at the time of virus inoculation; however, a primary antibody response did develop following virus inoculation. These findings demonstrate the variability in animal responses to BTV infection, especially to experimental infections.
The overall sensitivity of capture PCR, virus iso-lation, and antigen-capture ELISA were similar (Table  2) . By using the capture PCR, BTV RNA from as little as 1 CCID 50 could be detected in 10 hours. The capture PCR indicates only that BTV RNA is present; it does not necessarily indicate the presence of infectious virus. This procedure, although not as sensitive as other protocols, does predict the peak of bluetongue viremia; thus, it is useful as a prescreening tool for field investigations by reducing the number of samples that must be screened by virus isolation.
